Hasmet A Hanagasi Selected Research

Therapeutics

3/2004

Clozapine treatment in oromandibular dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hasmet A Hanagasi Research Topics

Disease

6	Dementia (Dementias) 06/2015 - 04/2005
4	Parkinsonian Disorders (Parkinsonism) 01/2016 - 01/2009
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2011
3	Cognitive Dysfunction 11/2016 - 08/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2021
1	Hepatolenticular Degeneration (Wilson's Disease) 09/2021
1	Neurologic Manifestations (Neurological Manifestations) 09/2021
1	Ataxia (Dyssynergia) 01/2021
1	Hiccup (Hiccups) 01/2021
1	Cerebrotendinous Xanthomatosis 01/2019
1	Neurodegeneration with brain iron accumulation (NBIA) 01/2017
1	Neoplasms (Cancer) 11/2016
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 11/2016
1	Encephalitis (Encephalitis, Rasmussen) 11/2016
1	Ovarian Teratoma 11/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016
1	REM Sleep Behavior Disorder 01/2014
1	Autoimmune Diseases of the Nervous System 01/2014
1	Chronic Disease (Chronic Diseases) 12/2013
1	Autoimmune Diseases (Autoimmune Disease) 12/2013
1	Frontotemporal Dementia (Semantic Dementia) 09/2013
1	Dyskinesias (Dyskinesia) 01/2013
1	Pain (Aches) 01/2011
1	Botulism 05/2010
1	Psychotic Disorders (Schizoaffective Disorder) 04/2005
1	Dystonia (Limb Dystonia) 03/2004
1	Dystonic Disorders (Writer's Cramp) 03/2004

Drug/Important Bio-Agent (IBA)

3	Levodopa (L Dopa)FDA LinkGeneric 01/2021 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2013
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2021 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2016 - 01/2014
2	AntibodiesIBA 11/2016 - 01/2014
2	rasagiline (Azilect)FDA Link 06/2015 - 08/2011
2	Antipsychotic Agents (Antipsychotics)IBA 04/2005 - 03/2004
2	Clozapine (Clozaril)FDA LinkGeneric 04/2005 - 03/2004
1	CytokinesIBA 01/2022
1	CopperIBA 09/2021
1	BenzodiazepinesIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	LipidsIBA 01/2019
1	Glutens (Glutelin)IBA 12/2013
1	OrexinsIBA 09/2013
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2013
1	Amyloid (Amyloid Fibrils)IBA 08/2012
1	sepiapterin reductaseIBA 02/2012
1	Monoamine Oxidase (MAO)IBA 08/2011
1	Type A Botulinum Toxins (Botox)FDA Link 05/2010
1	Dihydroxyphenylalanine (Dopa)IBA 01/2009
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2005

Therapy/Procedure

1	Activities of Daily Living (ADL) 01/2021
1	Injections 05/2010
1	Polypharmacy 04/2005
1	Therapeutics 03/2004